• No results found

This study indicates that there is some difference in expression of IL-7 and IL-7R in the different organs and mice. More research has to be done to see how relevant the difference is.

For the future, bigger sets of mice and more parallels can be done to get a more accurate set of results.

42

6 References

1. Helms RP, BCNSPQuan., PharmD. DJ, Herfindal ETP, MPH., Gourley DRP. Textbook of Therapeutics: Drug and Disease Management: Lippincott Williams & Wilkins; 2006. 2700 p.

2. Tsokos GC. Systemic Lupus Erythematosus. New England Journal of Medicine.

2011;365(22):2110-21.

3. Buyon J. Systemic Lupus Erythematosus. In: Klippel J, Stone J, Crofford L, White P, editors.

Primer on the Rheumatic Diseases: Springer New York; 2008. p. 303-38.

4. Espeli M, Bökers S, Giannico G, Dickinson HA, Bardsley V, Fogo AB, et al. Local Renal Autoantibody Production in Lupus Nephritis. Journal of the American Society of Nephrology : JASN.

2011;22(2):296-305.

5. Madhok R, Wu O. Systemic lupus erythematosus. BMJ Clinical Evidence. 2009;2009:1123.

6. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis & Rheumatism.

1982;25(11):1271-7.

7. Guidelines for referral and management of systemic lupus erythematosus in adults. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines. Arthritis Rheum. 1999;42(9):1785-96.

8. Kanapathippillai P, Hedberg A, Fenton CG, Fenton KA. Nucleosomes contribute to increase mesangial cell chemokine expression during the development of lupus nephritis. Cytokine.

2013;62(2):244-52.

9. Balow JE. Clinical presentation and monitoring of lupus nephritis. Lupus. 2005;14(1):25-30.

10. Mandache E, Penescu M. Renal subcapsular tertiary lymphoid aggregates in chronic kidney diseases. Rom J Morphol Embryol. 2011;52(4):1219-25.

11. Markowitz GS, D'Agati VD. The ISN//RPS 2003 classification of lupus nephritis: An assessment at 3 years. Kidney Int. 2007;71(6):491-5.

12. Ruddle NH. Lymphatic vessels and tertiary lymphoid organs. The Journal of Clinical Investigation. 2014;124(3):953-9.

13. Stranford S, Ruddle NH. Follicular dendritic cells, conduits, lymphatic vessels, and high endothelial venules in tertiary lymphoid organs: Parallels with lymph node stroma. Frontiers in Immunology. 2012;3:350.

14. Neyt K, Perros F, GeurtsvanKessel CH, Hammad H, Lambrecht BN. Tertiary lymphoid organs in infection and autoimmunity. Trends in Immunology. 2012;33(6):297-305.

15. Pimenta EM, Barnes BJ. Role of Tertiary Lymphoid Structures (TLS) in Anti-Tumor Immunity:

Potential Tumor-Induced Cytokines/Chemokines that Regulate TLS Formation in Epithelial-Derived Cancers. Cancers. 2014;6(2):969-97.

16. Carragher DM, Rangel-Moreno J, Randall TD. Ectopic lymphoid tissues and local immunity.

Seminars in Immunology. 2008;20(1):26-42.

17. Kirsh AL, Cushing SL, Chen EY, Schwartz SM, Perkins JA. Tertiary Lymphoid Organs in Lymphatic Malformations. Lymphatic Research and Biology. 2011;9(2):85-92.

18. Aloisi F, Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol. 2006;6(3):205-17.

19. Iolyeva M, Aebischer D, Proulx ST, Willrodt AH, Ecoiffier T, Haner S, et al. Interleukin-7 is produced by afferent lymphatic vessels and supports lymphatic drainage. Blood. 2013;122(13):2271-81.

20. Onder L, Narang P, Scandella E, Chai Q, Iolyeva M, Hoorweg K, et al. IL-7-producing stromal cells are critical for lymph node remodeling. Blood. 2012;120(24):4675-83.

21. Finke D, Schmutz S. Interleukin 7-induced lymphoid neogenesis in arthritis: recapitulation of a fetal developmental programme? Swiss Med Wkly. 2008;138(35-36):500-5.

43 22. Huang H-Y, Luther SA. Expression and function of interleukin-7 in secondary and tertiary lymphoid organs. Seminars in Immunology. 2012;24(3):175-89.

23. Kang J, Coles M. IL-7: the global builder of the innate lymphoid network and beyond, one niche at a time. Seminars in immunology. 2012;24(3):190-7.

24. Hartgring SA, van Roon JA, Wenting-van Wijk M, Jacobs KM, Jahangier ZN, Willis CR, et al.

Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis. Arthritis Rheum. 2009;60(9):2595-605.

25. Coles MC, Veiga-Fernandes H, Foster KE, Norton T, Pagakis SN, Seddon B, et al. Role of T and NK cells and IL7/IL7r interactions during neonatal maturation of lymph nodes. Proceedings of the National Academy of Sciences of the United States of America. 2006;103(36):13457-62.

26. Meier D, Bornmann C, Chappaz S, Schmutz S, Otten LA, Ceredig R, et al. Ectopic Lymphoid-Organ Development Occurs through Interleukin 7-Mediated Enhanced Survival of Lymphoid-Tissue-Inducer Cells. Immunity. 2007;26(5):643-54.

27. Tammela T, Alitalo K. Lymphangiogenesis: Molecular Mechanisms and Future Promise. Cell.

2010;140(4):460-76.

28. Popa C, Netea MG, van Riel PL, van der Meer JW, Stalenhoef AF. The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. J Lipid Res.

2007;48(4):751-62.

29. Zelová H, Hošek J. TNF-α signalling and inflammation: interactions between old acquaintances. Inflamm Res. 2013;62(7):641-51.

30. Apostolaki M, Armaka M, Victoratos P, Kollias G. Cellular mechanisms of TNF function in models of inflammation and autoimmunity. Curr Dir Autoimmun. 2010;11:1-26.

31. Feldmann M, Maini RN. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol. 2001;19:163-96.

32. Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol. 2003;3(9):745-56.

33. Xu J, Yin Z, Cao S, Gao W, Liu L, Yin Y, et al. Systematic Review and Meta-Analysis on the Association between IL-1B Polymorphisms and Cancer Risk. PLoS ONE. 2013;8(5):e63654.

34. Correia-Álvarez E, Gómez E, Martín D, Carrocera S, Pérez S, Otero J, et al. Expression and localization of interleukin 1 beta and interleukin 1 receptor (type I) in the bovine endometrium and embryo. Journal of Reproductive Immunology. 2015;110(0):1-13.

35. Bird S, Zou J, Wang T, Munday B, Cunningham C, Secombes CJ. Evolution of interleukin-1β.

Cytokine & Growth Factor Reviews. 2002;13(6):483-502.

36. Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases.

Blood. 2011;117(14):3720-32.

37. Gan SD, Patel KR. Enzyme Immunoassay and Enzyme-Linked Immunosorbent Assay. J Invest Dermatol. 2013;133(9):e12.

38. Cell Lysis Solutions Life technologies website: Life technologies. Available from:

https://www.lifetechnologies.com/no/en/home/life-science/protein-biology/protein-biology-learning-center/protein-biology-resource-library/pierce-protein-methods/cell-lysis-solutions.html.

39. Protein Sample Preparation Handbook GE Healthcare Life Sciences: GE Healthcare Life Sciences. Available from:

http://wolfson.huji.ac.il/purification/PDF/Protein_Expression_Extraction/GE_ProteinSamplePreparat ionHandbook.pdf.

40. How the Direct Detect® spectrometer uses FTIR Technology for protein quantitation: Merck Millipore. Available from: http://www.merckmillipore.com/NO/en/life-science-research/protein-

detection-quantification/direct-detect-spectrometer/ftir-technology/Bi2b.qB.wJMAAAFB21kRRkw8,nav.

41. Mahmood T, Yang P-C. Western Blot: Technique, Theory, and Trouble Shooting. North American Journal of Medical Sciences. 2012;4(9):429-34.

42. Shi SR, Taylor CR. Antigen Retrival. Available from: http://www.dako.com/no/ihc-guidebook-antigen-retrieval-chapter3.pdf.

44 43. Shi S-R, Shi Y, Taylor CR. Antigen Retrieval Immunohistochemistry: Review and Future

Prospects in Research and Diagnosis over Two Decades. Journal of Histochemistry and Cytochemistry. 2011;59(1):13-32.

44. RNeasy Mini Handbook 2012. Available from:

https://www.qiagen.com/no/resources/resourcedetail?id=14e7cf6e-521a-4cf7-8cbc-bf9f6fa33e24&lang=en.

45. Shi SR, Liu C, Taylor CR. Standardization of immunohistochemistry for formalin-fixed, paraffin-embedded tissue sections based on the antigen-retrieval technique: from experiments to hypothesis. J Histochem Cytochem. 2007;55(2):105-9.

46. cDNA synthesis New England biolabs. Available from:

https://www.neb.com/applications/dna-amplification-and-pcr/rt-pcr-and-cdna-synthesis/cdna-synthesis.

47. Technologies L. Simplified RT -- Reverse Transcription Animation. In: Technologies L, editor.

2012. p. 4:39 minutes.

48. Grove D. Quantitative real-time polymerase chain reaction for the core facility using TaqMan and the Perkin-Elmer/Applied Biosystems Division 7700 Sequence Detector. Journal of Biomolecular Techniques : JBT. 1999;10(1):11-6.

49. Technologies L. Essentials of Real-Time PCR

50. Link A, Vogt TK, Favre S, Britschgi MR, Acha-Orbea H, Hinz B, et al. Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat Immunol. 2007;8(11):1255-65.

51. Mazzucchelli RI, Warming S, Lawrence SM, Ishii M, Abshari M, Washington AV, et al.

Visualization and Identification of IL-7 Producing Cells in Reporter Mice. PLoS ONE. 2009;4(11):e7637.

52. Kang J, Coles M. IL-7: the global builder of the innate lymphoid network and beyond, one niche at a time. Semin Immunol. 2012;24(3):190-7.

53. Baluk P, Yao LC, Feng J, Romano T, Jung SS, Schreiter JL, et al. TNF-α drives remodeling of blood vessels and lymphatics in sustained airway inflammation in mice. Journal of Clinical Investigation. 2009;119(10):2954-64.

54. Arend WP. The balance between IL-1 and IL-1Ra in disease. Cytokine & Growth Factor Reviews. 2002;13(4–5):323-40.

55. Tam FWK, Smith J, Cashman SJ, Wang Y, Thompson EM, Rees AJ. Glomerular expression of interleukin-1 receptor antagonist and interleukin-1β genes in antibody-mediated glomerulonephritis.

American Journal of Pathology. 1994;145(1):126-36.

45